Aims and Scope of Current Gene Therapy
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less
Key Metrics
CiteScore 

5.8
Eigenfactor 

0.001 - 0.005
Impact Factor 

< 5
SJR 

Q3Genetics

SNIP 

0.89
Recommended pre-submission checks
Powered by 

Topics Covered on Current Gene Therapy
Current Gene Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Gene Therapy
Foxp3+ Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2-STAT3 Pathway in Ovarian Cancer Progression.
- 29 Oct 2025
- Current gene therapy
Attenuated Salmonella Carrying IL-21-siRNA-CCR2 Co-expression Plasmid Enhances Anti-tumor Immune Response in Lung Cancer-bearing Mice.
- 27 Oct 2025
- Current gene therapy
Preface-2026.
- 22 Oct 2025
- Current gene therapy
Revolution of Traditional Chinese Medicine in Anticancer Therapy, Applications and Future Perspective.
- 15 Oct 2025
- Current gene therapy
5-Alpha Reductase Deficiency - An Uncommon Disorder of Sexual Development: A Case Study of Four Turkish Patients within a Family.
- 14 Oct 2025
- Current gene therapy
SiRNA Knocking Down in HepG2 Cells Identifies PFKFB4 and HNF4α as Key Genes Important for Cancer Cell Survival.
- 1 Oct 2025
- Current gene therapy
Foxp3+ Tregs Promote M2 Macrophage Polarization via Sirt1-ERK1/2-STAT3 Pathway in Ovarian Cancer Progression.
- 29 Oct 2025
- Current gene therapy
Attenuated Salmonella Carrying IL-21-siRNA-CCR2 Co-expression Plasmid Enhances Anti-tumor Immune Response in Lung Cancer-bearing Mice.
- 27 Oct 2025
- Current gene therapy
Preface-2026.
- 22 Oct 2025
- Current gene therapy
Revolution of Traditional Chinese Medicine in Anticancer Therapy, Applications and Future Perspective.
- 15 Oct 2025
- Current gene therapy
5-Alpha Reductase Deficiency - An Uncommon Disorder of Sexual Development: A Case Study of Four Turkish Patients within a Family.
- 14 Oct 2025
- Current gene therapy
SiRNA Knocking Down in HepG2 Cells Identifies PFKFB4 and HNF4α as Key Genes Important for Cancer Cell Survival.
- 1 Oct 2025
- Current gene therapy
FAQs on Current Gene Therapy
How long has Current Gene Therapy been actively publishing? 
What is the publishing frequency of Current Gene Therapy? 
How many articles did Current Gene Therapy publish last year? 
What is the eISSN & pISSN for Current Gene Therapy? 
What is Citescore for Current Gene Therapy? 
What is SNIP score for Current Gene Therapy? 
What is the SJR for Current Gene Therapy? 
Who is the publisher of Current Gene Therapy? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary